PubMed · 11894430
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Henriette Lipczak, Anne Frølich, Peter Qvist, Lisbeth Rasmussen. 2002-03-04. [Standards development--I].. https://pubmed.ncbi.nlm.nih.gov/11894430/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
BACKGROUNDIncreasing incidence rates of invasive Streptococcus dysgalactiae subspecies equisimilis (iSDSE) have been detected worldwide.AIMWe aimed to investigate iSDSE infection incidence rates in Denmark during 2014-2024, and characterise the genomic population structure of a subset of iSDSE isolates and their antimicrobial resistance (AMR).METHODSUsing national register data, we estimated overall and sex-/age-stratified iSDSE incidences during 2014-2024, by retrospectively identifying cases of invasive infections with group C and G streptococci or S. dysgalactiae (including specified as subspecies equisimilis). From the voluntary national beta-haemolytic streptococci laboratory surveillance system, whole-genome-sequenced isolates from August 2020-September 2022 were used to investigate the iSDSE genomic population structure. Susceptibility to penicillin, erythromycin and clindamycin was determined and AMR genes identified.RESULTSDuring 2014-2024, iSDSE incidence rates increased significantly (linear trend analysis p < 0.001) with mean annual incidence ranging between 10.3 and 16.4 per 100,000, peaking in 2023. Incidence was higher in males, increasing with older age. Nearly 75% of the 1,223 iSDSE isolates belonged to four of 14 genetic clusters. Sequence types (STs) ST20 and ST17 were most prevalent, while emm-type stG62647, a variant associated internationally with higher virulence, dominated. All isolates were phenotypically susceptible to penicillin but approximately 10% were respectively erythromycin and clindamycin resistant. High erythromycin resistance prevalence (57%; 39/68), coinciding with gene ermA, occurred in one genetic cluster.CONCLUSIONThe findings illustrate the need for national registry-based surveillance to detect epidemiological changes and potential outbreaks. Further, continuous genomic surveillance can monitor the occurrence and expansion of genetic clades and AMR genes.
INTRODUCTION: This study describes the results obtained with a small IVF/ICSI-transport programme carried out between a private specialist clinic and a public IVF-clinic. MATERIALS AND METHODS: All women treated in the specialist clinic over a three and a half years period were entered. Ovarian stimulation, oocyte aspiration, and the follow-up after fertilisation were carried out in the specialist clinic, whereas fertilisation, culture and embryo transfer were performed in the public IVF clinic 25 km away. The oocytes were transported in an insulated box kept at 37 degrees C. RESULTS: Totally 314 stimulation cycles were performed with 68% IVF, 19% ICSI, and 13% cycles with cryopreserved oocytes (FER). The material comprises 259 oocyte aspirations with a total of 1969 oocytes, 1229 were fertilised. Oocyte and transfer-data are given in Table 2. The pregnancy rate was 29% for IVF and 27.1% for ICSI, but only 12.2% in FER. DISCUSSION: These results are consistent with that of other private and public IVF treatments in Denmark, where differences in population and oocyte handling are comparable (Table 3). As reported from the Netherlands, the UK, and Argentina (Table 4) transportation of oocytes does not seem to damage their potential for fertilisation and implantation.
Explore the source record for details and available documents.